Merck & Co. (NYSE: MRK) posted better-than-expected quarterly results Tuesday, despite profit being weighed down heavily by the deal the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE